90 of P2X7-associated pore or channel formation. Br J Pharmacol 147(3):324–334 59. Chimelli L, Scaravilli F (1997) Trypanosomiasis. Brain Pathol 7 (1):599–611 60. Engman DM, Leon JS (2002) Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop 81(2):123–132 61. Schmunis GA (1991) Trypanosoma cruzi, the etiologic agent of Chagas’ disease: status in the blood supply in endemic and nonendemic countries. Transfusion 31(6):547–557 62. Leite-de-Moraes MC, Hontebeyrie-Joskowicz M, Dardenne M, Savino W (1992) Modulation of thymocyte subsets during acute and chronic phases of experimental Trypanosoma cruzi infection. Immunology 77(1):95–98 63. Leite de Moraes MC, Hontebeyrie-Joskowicz M, Leboulenger F, Savino W, Dardenne M, Lepault F (1991) Studies on the thymus in Chagas’ disease. II. Thymocyte subset fluctuations in Trypa- nosoma cruzi-infected mice: relationship to stress. Scand J Immunol 33(3):267–275 64. Mantuano MB, Henriques-Pons A, Araujo-Jorge TC, Di Virgilio F, Coutinho-Silva R, Persechini PM (2003) Extracellular ATP induces cell death in CD4+/CD8+ double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes Infect 5 (15):1363–1371 65. Mantuano MB, Henriques-Pons A, Persechini PM, Araujo-Jorge TC, Coutinho CMLM, Coutinho-Silva R (2000) P2Z/P2X7 down- regulation: would it be evasion mechanism triggered by Trypano- soma cruzi. Drug Dev Res 50(1):61 66. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15(5):825–835 67. Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U, Dubyak GR, Proctor RA, Bertics PJ (2001) Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid- interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 167(4):1871–1876 68. Humphreys BD, Dubyak GR (1998) Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukocyte Biol 64(2):265–273 Purinergic Signalling (2007) 3:83–90 69. Eppell BA, Newell AM, Brown EJ (1989) Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. Implications for regulation of phagocytosis. J Immunol 143(12):4141–4145 70. Xaus J, Mirabet M, Lloberas J, Soler C, Lluis C, Franco R, Celada A (1999) IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deacti- vation. J Immunol 162(6):3607–3614 71. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, Brissette W, Wicks JR, Audoly L, Gabel CA (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168(12):6436– 6445 72. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P,Egerton J, Murfin M, Richardson J, Peck WL, Grahames CB, Casula MA, Yiangou Y, Birch R, Anand P, Buell GN (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114(3):386–396 73. Gourine AV, Poputnikov DM, Zhernosek N, Melenchuk EV, Gerstberger R, Spyer KM, Gourine VN (2005) P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats. Br J Pharmacol 146(1):139–145 74. Luttikhuizen DT, Harmsen MC, de Leij LF, van Luyn MJ (2004) Expression of P2 receptors at sites of chronic inflammation. Cell Tissue Res 317(3):289–298 75. Kaufmann A, Musset B, Limberg SH, Renigunta V, Sus R, Dalpke AH, Heeg KM, Robaye B, Hanley PJ (2005) “Host tissue damage” signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human mono- cytes. J Biol Chem 280(37):32459–32467 76. Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13(1):114–119 77. Di Virgilio F (2005) Purinergic mechanism in the immune system: a signal of danger for dendritic cells. Purinergic Signalling 1 (3):205–209 78. Byrne GI, Ojcius DM (2004) Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2 (10):802–808